ONC

Oncolytics Biotech (ONC)

Oncolytics Biotech Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:TSX:ONC

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/09/26	21 : 00	PR Newswire (US)	THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS	TSX:ONC	Oncolytics Biotech Inc
2022/06/02	01 : 23	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - ONC.WT	TSX:ONC	Oncolytics Biotech Inc
2022/06/02	01 : 21	PR Newswire (Canada)	IIROC Trading Halt - ONC.WT	TSX:ONC	Oncolytics Biotech Inc
2022/01/11	01 : 57	PR Newswire (US)	New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024	TSX:ONC	Oncolytics Biotech Inc
2022/01/11	01 : 54	PR Newswire (US)	New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024	TSX:ONC	Oncolytics Biotech Inc
2021/04/10	00 : 56	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - ONC	TSX:ONC	Oncolytics Biotech Inc
2021/04/10	00 : 56	PR Newswire (Canada)	IIROC Trade Resumption - ONC	TSX:ONC	Oncolytics Biotech Inc
2021/04/10	00 : 53	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - ONC	TSX:ONC	Oncolytics Biotech Inc
2021/04/10	00 : 52	PR Newswire (Canada)	IIROC Trading Halt - ONC	TSX:ONC	Oncolytics Biotech Inc
2021/02/18	00 : 08	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - ONC	TSX:ONC	Oncolytics Biotech Inc
2021/02/18	00 : 07	PR Newswire (Canada)	IIROC Trade Resumption - ONC	TSX:ONC	Oncolytics Biotech Inc
2021/02/17	23 : 58	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - ONC	TSX:ONC	Oncolytics Biotech Inc
2021/02/17	23 : 56	PR Newswire (Canada)	IIROC Trading Halt - ONC	TSX:ONC	Oncolytics Biotech Inc
2020/03/25	06 : 06	PR Newswire (Canada)	IIROC Trade Resumption - ONC	TSX:ONC	Oncolytics Biotech Inc
2020/03/25	04 : 00	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - ONC	TSX:ONC	Oncolytics Biotech Inc
2020/03/25	03 : 48	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - ONC	TSX:ONC	Oncolytics Biotech Inc
2020/03/25	03 : 47	PR Newswire (Canada)	IIROC Trading Halt - ONC	TSX:ONC	Oncolytics Biotech Inc
2020/03/25	01 : 56	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - ONC	TSX:ONC	Oncolytics Biotech Inc
2020/03/25	01 : 54	PR Newswire (Canada)	IIROC Trade Resumption - ONC	TSX:ONC	Oncolytics Biotech Inc
2020/03/25	01 : 41	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - ONC	TSX:ONC	Oncolytics Biotech Inc
2020/03/25	01 : 39	PR Newswire (Canada)	IIROC Trading Halt - ONC	TSX:ONC	Oncolytics Biotech Inc
2020/03/24	23 : 33	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - ONC	TSX:ONC	Oncolytics Biotech Inc
2020/03/24	23 : 31	PR Newswire (Canada)	IIROC Trade Resumption - ONC	TSX:ONC	Oncolytics Biotech Inc
2020/03/24	23 : 28	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - ONC	TSX:ONC	Oncolytics Biotech Inc
2020/03/24	23 : 26	PR Newswire (Canada)	IIROC Trading Halt - ONC	TSX:ONC	Oncolytics Biotech Inc
2017/12/27	21 : 00	PR Newswire (US)	Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patien...	TSX:ONC	Oncolytics Biotech Inc
2017/12/27	21 : 00	PR Newswire (Canada)	Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patien...	TSX:ONC	Oncolytics Biotech Inc
2017/12/05	21 : 00	PR Newswire (US)	Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic B...	TSX:ONC	Oncolytics Biotech Inc
2017/12/05	21 : 00	PR Newswire (Canada)	Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic B...	TSX:ONC	Oncolytics Biotech Inc
2017/12/04	21 : 00	PR Newswire (US)	Oncolytics Biotech® to Present at the Oncolytic Virotherapy Summit	TSX:ONC	Oncolytics Biotech Inc